List of Tables
    Table 1. Tumor Necrosis Factor Receptor Superfamily Member 1A CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Tumor Necrosis Factor Receptor Superfamily Member 1A Market Trends
    Table 3. Tumor Necrosis Factor Receptor Superfamily Member 1A Market Drivers
    Table 4. Tumor Necrosis Factor Receptor Superfamily Member 1A Market Challenges
    Table 5. Tumor Necrosis Factor Receptor Superfamily Member 1A Market Restraints
    Table 6. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Tumor Necrosis Factor Receptor Superfamily Member 1A Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Share by Manufacturer, 2017-2022
    Table 15. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Tumor Necrosis Factor Receptor Superfamily Member 1A by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Necrosis Factor Receptor Superfamily Member 1A as of 2021)
    Table 18. Top Players of Tumor Necrosis Factor Receptor Superfamily Member 1A in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 1A Product Type
    Table 20. Date of International Manufacturers Enter into Tumor Necrosis Factor Receptor Superfamily Member 1A Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Tumor Necrosis Factor Receptor Superfamily Member 1A Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Addex Therapeutics Ltd Corporation Information
    Table 43. Addex Therapeutics Ltd Description and Business Overview
    Table 44. Addex Therapeutics Ltd Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Addex Therapeutics Ltd Tumor Necrosis Factor Receptor Superfamily Member 1A Product
    Table 46. Addex Therapeutics Ltd Recent Development
    Table 47. G&E Herbal Biotechnology Co., Ltd. Corporation Information
    Table 48. G&E Herbal Biotechnology Co., Ltd. Description and Business Overview
    Table 49. G&E Herbal Biotechnology Co., Ltd. Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. G&E Herbal Biotechnology Co., Ltd. Product
    Table 51. G&E Herbal Biotechnology Co., Ltd. Recent Development
    Table 52. GlaxoSmithKline Plc Corporation Information
    Table 53. GlaxoSmithKline Plc Description and Business Overview
    Table 54. GlaxoSmithKline Plc Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. GlaxoSmithKline Plc Product
    Table 56. GlaxoSmithKline Plc Recent Development
    Table 57. Inflamalps SA Corporation Information
    Table 58. Inflamalps SA Description and Business Overview
    Table 59. Inflamalps SA Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Inflamalps SA Product
    Table 61. Inflamalps SA Recent Development
    Table 62. Polaris Pharmaceuticals, Inc. Corporation Information
    Table 63. Polaris Pharmaceuticals, Inc. Description and Business Overview
    Table 64. Polaris Pharmaceuticals, Inc. Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Polaris Pharmaceuticals, Inc. Product
    Table 66. Polaris Pharmaceuticals, Inc. Recent Development
    Table 67. Key Raw Materials Lists
    Table 68. Raw Materials Key Suppliers Lists
    Table 69. Tumor Necrosis Factor Receptor Superfamily Member 1A Customers List
    Table 70. Tumor Necrosis Factor Receptor Superfamily Member 1A Distributors List
    Table 71. Research Programs/Design for This Report
    Table 72. Key Data Information from Secondary Sources
    Table 73. Key Data Information from Primary Sources
List of Figures
    Figure 1. Tumor Necrosis Factor Receptor Superfamily Member 1A Product Picture
    Figure 2. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size 2017-2028 (US$ Million)
    Figure 4. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales 2017-2028 (K Units)
    Figure 5. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size 2017-2028 (US$ Million)
    Figure 7. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales 2017-2028 (K Units)
    Figure 8. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Tumor Necrosis Factor Receptor Superfamily Member 1A Report Years Considered
    Figure 11. Product Picture of LY-3232094
    Figure 12. Product Picture of EYS-606
    Figure 13. Product Picture of SRT-100
    Figure 14. Product Picture of Others
    Figure 15. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Share by Type in 2022 & 2028
    Figure 16. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Type (2017-2028) & (K Units)
    Figure 19. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price by Type (2017-2028) & (USD/Unit)
    Figure 21. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Market Share by Type in 2022 & 2028
    Figure 22. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Type (2017-2028) & (K Units)
    Figure 25. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Price by Type (2017-2028) & (USD/Unit)
    Figure 27. Product Picture of Genital Warts
    Figure 28. Product Picture of Melanoma
    Figure 29. Product Picture of Multiple Sclerosis
    Figure 30. Product Picture of Psoriasis
    Figure 31. Product Picture of Others
    Figure 32. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Share by Application in 2022 & 2028
    Figure 33. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 34. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Application (2017-2028)
    Figure 35. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application (2017-2028) & (K Units)
    Figure 36. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Application (2017-2028)
    Figure 37. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price by Application (2017-2028) & (USD/Unit)
    Figure 38. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Market Share by Application in 2022 & 2028
    Figure 39. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 40. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Value by Application (2017-2028)
    Figure 41. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application (2017-2028) & (K Units)
    Figure 42. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share in Volume by Application (2017-2028)
    Figure 43. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Price by Application (2017-2028) & (USD/Unit)
    Figure 44. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. U.S. Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Canada Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 49. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 50. Germany Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. France Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.K. Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Italy Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Russia Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 56. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 57. China Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Japan Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. South Korea Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. India Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Australia Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Taiwan Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Indonesia Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Thailand Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Malaysia Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Philippines Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 68. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Mexico Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Brazil Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Argentina Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 73. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 74. Turkey Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Saudi Arabia Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. U.A.E Tumor Necrosis Factor Receptor Superfamily Member 1A Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. Tumor Necrosis Factor Receptor Superfamily Member 1A Value Chain
    Figure 78. Tumor Necrosis Factor Receptor Superfamily Member 1A Production Process
    Figure 79. Channels of Distribution
    Figure 80. Distributors Profiles
    Figure 81. Bottom-up and Top-down Approaches for This Report
    Figure 82. Data Triangulation
    Figure 83. Key Executives Interviewed